Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )Open Access

Tamoxifen-Induced Dyslipidemia in Hormone Receptor-Positive Breast Cancer Patients: A Cross-Sectional Study among Kurdish Population

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDarya Salih HusseinRARezvan Abduljabbar

Discussion

Loading...

Member takes

Overview

Cross-sectional study reveals tamoxifen's limited effects on lipid profiles in over 160 Kurdish patients, suggesting BMI has a greater influence.

Key Points

  • Abnormal lipid profiles were more frequent in obese patients, highlighting the significant role of BMI.
  • Among patients, 56.1% had normal lipid profiles, while 32.4% exhibited elevated levels of cholesterol and triglycerides.
  • This cross-sectional study was conducted on 165 Kurdish women with hormone receptor-positive breast cancer receiving tamoxifen treatment.
  • Tamoxifen treatment duration showed minimal impact on lipid profiles, indicating that other factors may be more influential.

Cite This Study

Hussein et al. (2025) studied this question.

synapsesocial.com/papers/68e040eda99c246f578b326fhttps://doi.org/10.54133/ajms.v9i2.2284
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights.2026
  2. 2Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancer2025
  3. 3Indications for primary tamoxifen therapy in elderly women with breast cancer1992 · 49 citations
  4. 4Baseline dyslipidemia in treatment-naïve breast cancer: Molecular subtype–specific patterns in a large cohort.2026
  5. 5Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study2025